Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9572894rdf:typepubmed:Citationlld:pubmed
pubmed-article:9572894lifeskim:mentionsumls-concept:C0003392lld:lifeskim
pubmed-article:9572894lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:9572894lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:9572894lifeskim:mentionsumls-concept:C0674571lld:lifeskim
pubmed-article:9572894pubmed:issue10lld:pubmed
pubmed-article:9572894pubmed:dateCreated1998-5-28lld:pubmed
pubmed-article:9572894pubmed:abstractTextA structure-activity relationship (SAR) study of the South African willow tree (Combretum caffrum) antineoplastic constituent combretastatin A-4 (1b) directed at maintaining the (Z)-stilbene relationship of the olefin diphenyl substituents led to synthesis of a potent cancer cell growth inhibitor designated phenstatin (3b). Initially phenstatin silyl ether (3a) was unexpectedly obtained by Jacobsen oxidation of combretastatin A-4 silyl ether (1c --> 3a), and the parent phenstatin (3b) was later synthesized (6a --> 3a --> 3b) in quantity. Phenstatin was converted to the sodium phosphate prodrug (3d) by a dibenzyl phosphite phosphorylation and subsequent hydrogenolysis sequence (3b --> 3c --> 3d). Phenstatin (3b) inhibited growth of the pathogenic bacterium Neisseriagonorrhoeae and was a potent inhibitor of tubulin polymerization and the binding of colchicine to tubulin comparable to combretastatin A-4 (1b). Interestingly, the prodrugs were found to have reduced activity in these biochemical assays. While no significant tubulin activity was observed with the phosphorylated derivative of combretastatin A-4 (1d), phosphate 3d retained detectable inhibitory effects in both assays.lld:pubmed
pubmed-article:9572894pubmed:languageenglld:pubmed
pubmed-article:9572894pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9572894pubmed:citationSubsetIMlld:pubmed
pubmed-article:9572894pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9572894pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9572894pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9572894pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9572894pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9572894pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9572894pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9572894pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9572894pubmed:statusMEDLINElld:pubmed
pubmed-article:9572894pubmed:monthMaylld:pubmed
pubmed-article:9572894pubmed:issn0022-2623lld:pubmed
pubmed-article:9572894pubmed:authorpubmed-author:BoydM RMRlld:pubmed
pubmed-article:9572894pubmed:authorpubmed-author:HamelEElld:pubmed
pubmed-article:9572894pubmed:authorpubmed-author:PettitG RGRlld:pubmed
pubmed-article:9572894pubmed:authorpubmed-author:HeraldD LDLlld:pubmed
pubmed-article:9572894pubmed:authorpubmed-author:PettitR KRKlld:pubmed
pubmed-article:9572894pubmed:authorpubmed-author:Verdier-Pinar...lld:pubmed
pubmed-article:9572894pubmed:authorpubmed-author:TokiBBlld:pubmed
pubmed-article:9572894pubmed:issnTypePrintlld:pubmed
pubmed-article:9572894pubmed:day7lld:pubmed
pubmed-article:9572894pubmed:volume41lld:pubmed
pubmed-article:9572894pubmed:ownerNLMlld:pubmed
pubmed-article:9572894pubmed:authorsCompleteYlld:pubmed
pubmed-article:9572894pubmed:pagination1688-95lld:pubmed
pubmed-article:9572894pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9572894pubmed:meshHeadingpubmed-meshheading:9572894-...lld:pubmed
pubmed-article:9572894pubmed:meshHeadingpubmed-meshheading:9572894-...lld:pubmed
pubmed-article:9572894pubmed:meshHeadingpubmed-meshheading:9572894-...lld:pubmed
pubmed-article:9572894pubmed:meshHeadingpubmed-meshheading:9572894-...lld:pubmed
pubmed-article:9572894pubmed:meshHeadingpubmed-meshheading:9572894-...lld:pubmed
pubmed-article:9572894pubmed:meshHeadingpubmed-meshheading:9572894-...lld:pubmed
pubmed-article:9572894pubmed:meshHeadingpubmed-meshheading:9572894-...lld:pubmed
pubmed-article:9572894pubmed:meshHeadingpubmed-meshheading:9572894-...lld:pubmed
pubmed-article:9572894pubmed:meshHeadingpubmed-meshheading:9572894-...lld:pubmed
pubmed-article:9572894pubmed:meshHeadingpubmed-meshheading:9572894-...lld:pubmed
pubmed-article:9572894pubmed:meshHeadingpubmed-meshheading:9572894-...lld:pubmed
pubmed-article:9572894pubmed:meshHeadingpubmed-meshheading:9572894-...lld:pubmed
pubmed-article:9572894pubmed:meshHeadingpubmed-meshheading:9572894-...lld:pubmed
pubmed-article:9572894pubmed:meshHeadingpubmed-meshheading:9572894-...lld:pubmed
pubmed-article:9572894pubmed:meshHeadingpubmed-meshheading:9572894-...lld:pubmed
pubmed-article:9572894pubmed:meshHeadingpubmed-meshheading:9572894-...lld:pubmed
pubmed-article:9572894pubmed:meshHeadingpubmed-meshheading:9572894-...lld:pubmed
pubmed-article:9572894pubmed:meshHeadingpubmed-meshheading:9572894-...lld:pubmed
pubmed-article:9572894pubmed:meshHeadingpubmed-meshheading:9572894-...lld:pubmed
pubmed-article:9572894pubmed:year1998lld:pubmed
pubmed-article:9572894pubmed:articleTitleAntineoplastic agents. 379. Synthesis of phenstatin phosphate.lld:pubmed
pubmed-article:9572894pubmed:affiliationCancer Research Institute and Department of Chemistry, Arizona State University, Tempe, Arizona 85287-1604, USA.lld:pubmed
pubmed-article:9572894pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9572894pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9572894pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:9572894lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9572894lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9572894lld:pubmed